Learn more

TETRALOGIC PHARM CORP

Overview
  • Total Patents
    88
  • GoodIP Patent Rank
    176,638
About

TETRALOGIC PHARM CORP has a total of 88 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are CURIS INC, SAPPHIRE THERAPEUTICS INC and DAJITI SANKIO KOMPANI LTD.

Patent filings per year

Chart showing TETRALOGIC PHARM CORPs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Laporte Matthew G 65
#2 Condon Stephen M 65
#3 Deng Yijun 57
#4 Rippin Susan R 45
#5 Chunduru Srinivas 11
#6 Alexander Matthew D 9
#7 Begley C Glenn 8
#8 Haimowitz Thomas 7
#9 Benetatos Christopher 7
#10 Yijun Deng 6

Latest patents

Publication Filing date Title
WO2015017520A1 Method of treatment
US2014303090A1 Smac Mimetic Therapy
WO2014121178A1 Smac mimetic method of treatment
EP2879707A1 Combination therapy
WO2013049350A1 Smac mimetic (birinapant) for use in the treatment of proliferative diseases (cancer)
AU2012202098A1 Dimeric IAP antagonists
WO2011068926A1 Iap inhibitors
CN102458116A IAP inhibitors
NZ596669A Iap inhibitors
CA2736505A1 Iap inhibitors
EP2242362A1 Iap inhibitors
AU2007276760A1 Dimeric IAP antagonists
EP2385038A1 Dimeric IAP inhibitors